Evidence map›Paper›PMID 41220740›Full record

ArticleJournal of gastrointestinal oncology2025

Global, regional, and national burden of gastrointestinal cancers in early onset and young women, 1990-2021: analysis of data from the Global Burden of Disease study 2021.

Yinghong Li, Mingjie Tang, Shiwei Li, Ziwen Li, Zhaoming Chen, Jiqin Tang, Peng Shu, Weixing Shen

Abstract read
In one paragraph

Article in Journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Yinghong LiDepartment of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Mingjie TangThe First College for Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Shiwei LiXiangya School of Medicine, Central South University, Changsha, China.
Ziwen LiThe First College for Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Zhaoming ChenDepartment of Acupuncture and Moxibustion, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.
Jiqin TangCollege of Rehabilitation Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Peng ShuDepartment of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Weixing ShenDepartment of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gastrointestinal (GI) cancers present a substantial challenge to public health. Research on the burden of GI cancers among early onset and young women is limited. This study aims to investigate the burden of GI cancers among women aged 15 to 49 years, thereby addressing the existing research gap. Methods: This study employed data from Global Burden of Disease (GBD) 2021 to assess the trends in incidence, prevalence, mortality, and Disability-Adjusted Life Years (DALYs) of GI cancers among early onset and young women from 1990 to 2021. The temporal trends were evaluated by calculating estimated annual percentage changes (EAPCs). The socio-demographic index (SDI) was employed to examine the relationship between burden-related indicators and socio-economic development. Results: In 2021, among GI cancers, colorectal cancer (CRC) and stomach cancer (SC) accounted for the predominant proportion of the age-standardized incidence rate (ASIR) and age-standardized prevalence rate (ASPR), with rates of 26.39 and 5.41 per 100,000, respectively. Moreover, CRC has been recognized as the principal contributor to age-standardized mortality rate (ASMR) and age-standardized DALY rate (ASDALYR), with respective rates of 1.57 and 79.49 per 100,000. A decline was observed in most GI cancers from 1990 to 2021, with SC exhibiting the most pronounced reduction. It is significant that the ASPR for CRC demonstrated a marginal increase. CRC, pancreatic cancer, and gallbladder and biliary tract cancer exhibited the highest ASIR in the high SDI region, while liver cancer and esophageal cancer had the highest ASIR in the low SDI region, and SC had the highest ASIR in the high-middle SDI region. GI cancers in early onset and young women have emerged as a significant global public health concern. Conclusions: GI cancers exhibit considerable regional and national variations in incidence, prevalence, mortality, and DALYs. Future research should focus on identifying risk factors in young women and optimizing early screening. Public health policies need to allocate resources based on regional disease burden and socio-economic status. Robust cancer registries and cross-resource sharing platforms for prevention and treatment are essential to reduce the global GI cancer burden in this population.

Indexed as

disability-adjusted life years (DALYs)early onset and young womenGastrointestinal cancers (GI cancers)Global Burden of Disease 2021 (GBD 2021)

Identifiers

PMID41220740
PMCPMC12598334

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.